Evonetix delivers first chip-synthesized DNA to the University of Cambridge

EVONETIX LTD (‘Evonetix’), the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge. This milestone marks the start of the next stage of development of the Company as it expands the range and scale of DNA synthesized on its desktop platform.

The DNA was delivered to Dr Jenny Molloy, Co-chair of the Engineering Biology Interdisciplinary Research Centre at the University of Cambridge. The successful testing of the DNA in Dr Molloy’s laboratory further validates Evonetix’s patented thermally controlled semiconductor technology and supports the further development of the Company’s desktop DNA synthesis platform, which is being developed to enable scientists to synthesize long DNA in their own lab, enabling the biology revolution.

“I’m delighted to have received the first DNA synthesized on Evonetix’s semiconductor chips. Rapid access to custom-designed DNA is a key challenge for us and Evonetix’s technology is an exciting new approach to meet the growing demand from researchers. Having the capability to quickly synthesize accurate, gene-length DNA in our own lab will revolutionize our ability to experiment and accelerate results across engineering biology.” 

Dr Jenny Molloy, Department of Chemical Engineering and Biotechnology at the University of Cambridge

Colin McCracken, Chief Executive Officer at Evonetix, commented: “We are proud to be collaborating with scientists at the University of Cambridge as part of our early access programme, delivering our high-fidelity DNA for use in research activities. Synthesizing the first user-ready DNA using our desktop platform is a huge accomplishment and a big step towards the development of our platform. Following our recent fundraise1, this achievement continues our work towards full commercialization of our technology.”

“Our technology brings together entirely new approaches to chemistry and process control to enable DNA synthesis in any lab. Having optimized each element of our technology, this milestone demonstrates that our platform can successfully synthesize DNA using our patented thermally controlled semiconductor chip technology and will allow us to begin expanding the scale of our synthesis.” 

Dr Matt Hayes, Chief Technology Officer at Evonetix

For more news from Evonetix, please visit: https://www.evonetix.com/news/

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evonetix. (2023, May 10). Evonetix delivers first chip-synthesized DNA to the University of Cambridge. News-Medical. Retrieved on June 25, 2024 from https://www.news-medical.net/news/20230510/Evonetix-delivers-first-chip-synthesized-DNA-to-the-University-of-Cambridge.aspx.

  • MLA

    Evonetix. "Evonetix delivers first chip-synthesized DNA to the University of Cambridge". News-Medical. 25 June 2024. <https://www.news-medical.net/news/20230510/Evonetix-delivers-first-chip-synthesized-DNA-to-the-University-of-Cambridge.aspx>.

  • Chicago

    Evonetix. "Evonetix delivers first chip-synthesized DNA to the University of Cambridge". News-Medical. https://www.news-medical.net/news/20230510/Evonetix-delivers-first-chip-synthesized-DNA-to-the-University-of-Cambridge.aspx. (accessed June 25, 2024).

  • Harvard

    Evonetix. 2023. Evonetix delivers first chip-synthesized DNA to the University of Cambridge. News-Medical, viewed 25 June 2024, https://www.news-medical.net/news/20230510/Evonetix-delivers-first-chip-synthesized-DNA-to-the-University-of-Cambridge.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Evonetix unveils new branding to align with its vision for gene-length DNA synthesis